Q1 FY27 Results Approved, MD Re-appointed for 5 Years

Emphasis Of MatterRevenue Growth 20pctPat Growth 25pctResults View source PDF

DOLPHIN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-5.5%1-day move

₹399.00

prior close

₹387.75

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.2—-0.2-2.2-5.5—————————

Up moveDown movePending

AI summary

Board approved Q1 FY27 unaudited results for quarter ended June 30, 2026. Standalone revenue from operations rose to Rs 246.33 lakhs (vs Rs 40 lakhs YoY), but PAT fell to Rs 91.08 lakhs (vs Rs 124.08 lakhs) on higher finance costs. Consolidated revenue jumped to Rs 4,284.65 lakhs (from Rs 1,644.30 lakhs), PAT grew to Rs 1,481.41 lakhs. Auditor flagged Emphasis of Matter on ECL provision of Rs 502.18 lakhs standalone and Rs 1,110.49 lakhs consolidated. MD Rupesh Savla re-appointed for 5 years.

Likely market impact

Strong consolidated growth but auditor flagged ECL provisions on receivables. Standalone PAT dipped. MD continuity is a positive.